Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
5
×
boston blog main
boston top stories
cancer immunotherapy
5
×
immunotherapy
5
×
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
san francisco blog main
san francisco top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
glaxosmithkline
indiana blog main
indiana top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
deals
fda
gene therapy
gilead sciences
medicare
nonalcoholic steatohepatitis
startups
What
roundup
bio
biotech
companies
days
drug
nash
new
news
abbvie’s
according
acquisitions
ahead
akcea
albert
approval
arrival
biggest
biofourmis
biogen’s
biopharmaceutical
bourla
bucks
cancer
cases
celebrate
centers
ceo
chance
cigarettes
company
control
convo
corner
crispr
day
deaths
disease
earlier
electronic
Language
unset
unknown
Current search:
immunotherapy
×
biotech
×
" cancer immunotherapy "
×
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More